Top

Published in:

01-06-2020 | Obesity | Editorial

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Authors: Laura M. Mongioì, Federica Barbagallo, Rosita A. Condorelli, Rossella Cannarella, Antonio Aversa, Sandro La Vignera, Aldo E. Calogero

Published in: Endocrine | Issue 3/2020

Abstract

The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is centralizing the interest of the scientific world. In the next months, long-term consequences on the endocrine system may arise following COVID-19. In this article, we hypothesized the effects of SARS-CoV-2 taking into account what learned from the severe acute respiratory syndrome coronavirus (SARS-CoV) that caused SARS in 2003.

F. Wu, S. Zhao, B. Yu, Y.M. Chen, W. Wang, Z.G. Song, Y. Hu, Z.W. Tao, J.H. Tian, Y.Y. Pei, M.L. Yuan, Y.L. Zhang, F.H. Dai, Y. Liu, Q.M. Wang, J.J. Zheng, L. Xu, E.C. Holmes, Y.Z. Zhang, A new coronavirus associated with human respiratory disease in China. Nature 579(7798), 265–269 (2020). https://doi.org/10.1038/s41586-020-2008-3.CrossRefPubMedPubMedCentral

J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, V.C. Cheng, K.H. Chan, D.N. Tsang, R.W. Yung, T.K. Ng, K.Y. Yuen,SARS study group, Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361(9366), 1319–1325 (2003).CrossRefPubMedPubMedCentral

Y. Ding, L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, S. Jiang, Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 203(2), 622–630 (2004).CrossRefPubMedPubMedCentral

M. Xie, Q. Chen, Insight into 2019 novel coronavirus—an updated intrim review and lessons from SARS-CoV and MERS-CoV. Int. J. Infect. Dis. (2020). S1201-9712(20)30204-6. https://doi.org/10.1016/j.ijid.2020.03.071.

J.W. Chan, C.K. Ng, Y.H. Chan, T.Y. Mok, S. Lee, S.Y. Chu, W.L. Law, M.P. Lee, P.C. Li, Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 58(8), 686–689 (2003).CrossRefPubMedPubMedCentral

J.K. Yang, Y. Feng, M.Y. Yuan, S.Y. Yuan, H.J. Fu, B.Y. Wu, G.Z. Sun, G.R. Yang, X.L. Zhang, L. Wang, X. Xu, X.P. Xu, J.C. Chan, Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet. Med. 23(6), 623–628 (2006).CrossRefPubMed

M. Puig-Domingo, M. Marazuela, A. Giustina, COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine 68(1), 2–5 (2020). https://doi.org/10.1007/s12020-020-02294-5.CrossRefPubMedPubMedCentral

J.K. Yang, S.S. Lin, X.J. Ji, L.M. Guo, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 47(3), 193–199 (2010). https://doi.org/10.1007/s00592-009-0109-4.CrossRefPubMed

Y. Ding, L. He, Q. Zhang, Z. Huang, X. Che, J. Hou, H. Wang, H. Shen, L. Qiu, Z. Li, J. Geng, J. Cai, H. Han, X. Li, W. Kang, D. Weng, P. Liang, S. Jiang, Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 203(2), 622–630 (2004).CrossRefPubMedPubMedCentral

10.

S. La Vignera, R. Cannarella, R.A. Condorelli, F. Torre, A. Aversa, A.E. Calogero, Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int. J. Mol. Sci. 21(8), E2948 (2020). https://doi.org/10.3390/ijms21082948.

11.

N. Sattar, I.B. McInnes, J.J.V. McMurray, Obesity a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation. (2020). https://doi.org/10.1161/CIRCULATIONAHA.120.047659.

12.

J. Lighter, M. Phillips, S. Hochman, S. Sterling, D. Johnson, F. Francois, A. Stachel, Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Clin. Infect. Dis. ciaa415 (2020). https://doi.org/10.1093/cid/ciaa415.

13.

F.P. de Heredia, S. Gómez-Martínez, A. Marcos, Obesity, inflammation and the immune system. Proc. Nutr. Soc. 71(2), 332–338 (2012). https://doi.org/10.1017/S0029665112000092.CrossRefPubMed

14.

W.D. Green, M.A. Beck, Obesity impairs the adaptive immune response to influenza virus. Ann. Am. Thorac. Soc. 14(Supplement_5), S406–S409 (2017). https://doi.org/10.1513/AnnalsATS.201706-447AW.CrossRefPubMedPubMedCentral

15.

R. Wheatland, Molecular mimicry of ACTH in SARS—implications for corticosteroid treatment and prophylaxis. Med. Hypotheses. 63(5), 855–862 (2004).CrossRefPubMedPubMedCentral

16.

M.K. Leow, D.S. Kwek, A.W. Ng, K.C. Ong, G.J. Kaw, L.S. Lee, Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin. Endocrinol. 63(2), 197–202 (2005).CrossRef

17.

C. Scaroni, M. Armigliato, S. Cannavò, COVID-19 outbreak and steroids administration: are patients treated for Sars-Cov-2 at risk of adrenal insufficiency? J. Endocrinol. Investig. (2020). https://doi.org/10.1007/s40618-020-01253-1.

18.

L. Wei, S. Sun, C.H. Xu, J. Zhang, Y. Xu, H. Zhu, S.C. Peh, C. Korteweg, M.A. McNutt, J. Gu, Pathology of the thyroid in severe acute respiratory syndrome. Hum. Pathol. 38(1), 95–102 (2007).CrossRefPubMed

19.

L. Wei, S. Sun, J. Zhang, H. Zhu, Y. Xu, Q. Ma, M.A. McNutt, C. Korteweg, J. Gu, Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem. Cell Biol. 88(4), 723–730 (2010). https://doi.org/10.1139/O10-022.CrossRefPubMed

20.

J. Lyons-Weiler, Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity. J. Transl. Autoimmun. 100051 (2020). https://doi.org/10.1016/j.jtauto.2020.100051.

21.

J. Xu, L. Qi, X. Chi, J. Yang, X. Wei, E. Gong, S. Peh, J. Gu, Orchitis: a complication of severe acute respiratory syndrome (SARS). Biol. Reprod. 74(2), 410–416 (2006).CrossRefPubMed

Title: Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model
Authors: Laura M. Mongioì
Federica Barbagallo
Rosita A. Condorelli
Rossella Cannarella
Antonio Aversa
Sandro La Vignera
Aldo E. Calogero
Publication date: 01-06-2020
Publisher: Springer US
Keywords: Obesity
Obesity
Severe Acute Respiratory Syndrome Coronavirus
SARS-CoV-2
COVID-19
Published in: Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02349-7

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Possible long-term endocrine-metabolic complications in COVID-19: lesson from the SARS model

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2020

Glucagon-like peptide-2 analog and inflammatory state in obese mice

Incidental versus clinically diagnosed differentiated thyroid cancer in both adult and elderly subjects: histological characteristics and follow-up in a retrospective analysis from a single institution

Diurnal rhythmicity in breast-milk glucocorticoids, and infant behavior and sleep at age 3 months

The role of AIP variants in pituitary adenomas and concomitant thyroid carcinomas in the Netherlands: a nationwide pathology registry (PALGA) study

Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging

Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page